|
|
Volumn 28, Issue 4, 1999, Pages 746-749
|
|
Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: Weighing the evidence
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
AZITHROMYCIN;
MACROLIDE;
ROXITHROMYCIN;
ANTIBIOTIC THERAPY;
ARTICLE;
ATHEROGENESIS;
ATHEROSCLEROSIS;
CARDIOVASCULAR RISK;
CHLAMYDIASIS;
CHLAMYDOPHILA PNEUMONIAE;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTION;
DISEASE ASSOCIATION;
DRUG EFFICACY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
SECONDARY PREVENTION;
SEROPREVALENCE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
VIRUS PATHOGENESIS;
|
|
EID: 0032902664
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/515216 Document Type: Article |
|
Times cited : (26)
|
|
References (25)
|
